Subscribe to our Newsletters !!
There is one fact about life on Earth we cannot es
In this application note, we demonstrate how the C
The Nobel Prize in Physiology or Medicine awarded
In today’s rapidly evolving bioprocessing landsc
Alembic Pharmaceutica
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Mi
The University of Oxford has established a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.
Approximately 300 volunteers will be registered and first inoculations are expected this month, Oxford said.
The two-dose Oxford/AstraZeneca vaccine was hailed as a’vaccine for the world’ because it’s cheaper and easier to distribute than some rivals.
AstraZeneca has a goal to produce 3 billion doses this year and intends to produce over 200 million doses daily by April.
